Silence Therapeutics (SLN) Current Assets (2018 - 2026)

Silence Therapeutics' Current Assets history runs 9 years deep, the most recent figure standing at $102.9 million for Q1 2026.

• In Q1 2026, Current Assets fell 39.42% year-over-year to $102.9 million; the TTM figure through Mar 2026 stood at $102.9 million (down 39.42% YoY), while the FY2025 annual figure was $118.7 million, down 36.67% from the prior year.
• Current Assets came in at $102.9 million for Q1 2026 at Silence Therapeutics, down from $118.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $230.5 million in Q1 2024 to a low of $92.5 million in Q2 2022.
• A 5-year average of $139.9 million and a median of $118.7 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 1107.62% in 2022 and sank 39.42% in 2026, its largest moves.
• Silence Therapeutics' Current Assets stood at $113.4 million in 2022, then declined by 11.33% to $100.6 million in 2023, then jumped by 86.32% to $187.4 million in 2024, then sank by 36.67% to $118.7 million in 2025, then slipped by 13.32% to $102.9 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $102.9 million, $118.7 million, and $133.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison